adBlockCheck

Business

President’s American Manufacturing Council Down To CEO Of Shoe Carnival

WASHINGTON—Following a series of resignations from prominent CEOs amid the fallout from President Trump’s handling of white-nationalist violence in Charlottesville, VA, White House sources confirmed Tuesday that Trump’s American Manufacturing Council is now down to a single member, Clifton Sifford, CEO and president of Shoe Carnival.

Listen, Area Boss Gets It

PHILADELPHIA—Readily admitting that everything you’re saying makes a lot of sense, Greenwave Media accounts manager Bryan Mellis confirmed on Wednesday that he totally gets it.

Tide Debuts New Sour Apple Detergent Pods

CINCINNATI—Calling it the perfect choice for consumers looking to add some tartness to their laundry, Procter and Gamble on Tuesday unveiled a new sour apple Tide detergent pod.

The iPhone Turns 10

A decade ago today, Apple released the iPhone and revolutionized the way humans use technology. Here’s a look back at the evolution of the iPhone:

Pros And Cons Of The Gig Economy

Americans are increasingly using on-demand services, both as workers and consumers. Here are the major benefits and drawbacks of the gig economy.

Frontier Airlines Tells Customers To Just Fucking Deal With It

‘You’re Uncomfortable For A Few Hours And Then You Get To Be Somewhere Else,’ Says CEO

DENVER—Noting that some discomfort should be expected while traveling to a faraway place in just a few goddamn hours, officials from ultra-low-cost carrier Frontier Airlines reportedly told customers Thursday to just fucking deal with it.
End Of Section
  • More News

Pfizer Mercifully Puts Down Another Batch Of Trial Patients

NEW YORK—Following unforeseen complications during a trial of the company’s new cholesterol medication Lipodrin, researchers at pharmaceutical manufacturer Pfizer said they were forced to put down another batch of test patients out of mercy Friday. “Initially the results were very promising, but after a third of our patients showed troubling side effects we had to make the difficult decision to terminate the subject group—at that point, it was the only humane thing to do,” said lead researcher Richard Dunn, confirming that this was the second test group in a week that had to be eliminated, following a group of 30 arthritis sufferers who had responded poorly to a new 300 mg formulation of Celebrex. “This is often an unfortunate part of the development stage, but I can assure you that not all is lost; with what we’ve been able to learn from this now-deceased cohort, we’re almost certain to earn FDA approval after the next series of trials.” Dunn further expressed his dismay that, since there was no longer anything to compare them against, the members of the study’s control group would also need to be euthanized.

More from this section

Listen, Area Boss Gets It

PHILADELPHIA—Readily admitting that everything you’re saying makes a lot of sense, Greenwave Media accounts manager Bryan Mellis confirmed on Wednesday that he totally gets it.

Sign up For The Onion's Newsletter

Give your spam filter something to do.

Close